🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

191 notícias encontradas para "drug"
Investigational drug that targets DNA damage help could treat Alzheimer's disease
Accumulation of DNA damage in the brain's neurons may contribute to the development of Alzheimer's disease. New research in FEBS Open Bio demonstrates the therapeutic potential of a drug that targets this process.
Ivermectin isn't a cancer miracle drug, but influencers claim otherwise
Though researchers have been studying the animal deworming drug ivermectin for decades, there is no evidence that it's a safe or effective way to treat cancer in people.
AI-guided CRISPR uncovers oxytocin receptor as unexpected psoriasis drug target
Biohub researchers have performed what they believe is the first genome-wide CRISPR study of primary human adult skin cells, then used an AI model to mine the results for overlooked drug targets for psoriasis. They found an unlikely candidate: the receptor for oxytocin, a hormone
Most obesity drugs do not improve quality of life or heart health, analysis indicates
Most obesity drugs do not improve quality of life or heart health, analysis indicates
Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life, and few show cardiovascular benefits at one year, according to an analysis of the latest evidence published by The BMJ.
Commonly used drugs show small benefit for long COVID fatigue
Over-the-counter antihistamines and a prescription anti-inflammatory drug both have a small benefit in reducing long COVID fatigue among people receiving care from specialist long COVID clinics, according to new findings from a large clinical trial led by UCL and UCLH.
Foto: Nataliya Vaitkevich / Pexels
GLP-1 agonists may help people with diabetes and long COVID, study in mice suggests
GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health benefits as well. Findings from experiments on mice, published in the Journal of Virology, suggest that the drugs may offer benefits to another patient popula
FDA expands use of first sickle cell disease gene therapy for children as young as 2 years
The U.S. Food and Drug Administration has issued a supplemental approval for Casgevy (exagamglogene autotemcel) for patients ages 2 and older with either sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) or transfusion-dependent β thalassemia (TDT). Supplement
Psychedelic drug screen in mice may overlook stress and brain changes
Over the past decades, some medical researchers and neuroscientists have been exploring the possible therapeutic effects of psychedelic compounds, such as lysergic acid diethylamide (LSD) and psilocybin. These are substances that act on serotonin receptors in the brain and can al
New treatment helps achieve a healthier BMI in people with weight dysregulation after brai
A new therapy helps achieve a healthier BMI in people whose weight has become dysregulated following treatment for a brain tumor, a clinical trial has found. The results of the trial have been published in the New England Journal of Medicine. The new drug, setmelanotide, offers h
New experimental approach may help overcome drug resistance in deadly brain cancer
Scientists have identified a promising new strategy to tackle one of the biggest obstacles in treating glioblastoma, one of the most aggressive forms of brain cancer: resistance to chemotherapy. The study shows that an experimental compound called BA-101 can restore the effective
Societies combine to issue recommendations on use of incretin drugs in obesity therapy
Obesity and dietitian societies have joined forces to issue a new consensus statement on recommendations surrounding the use of obesity drugs for weight loss treatment. The statement, which is published in The Lancet Diabetes & Endocrinology, is led by Dr. Laurence Dobbie of the
GLP-1 use hits record high as Medicare opens access to weight-loss drugs
The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%. O recorte ajuda a contextualizar a pauta dentro de Fitness.